Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters
Scholar

Donna Harrison, M.D.

Associate Scholar

Dr. Donna Harrison is a physician, board-certified in obstetrics and gynecology for 30 years. She is currently serving as Director of Research for the American Association of Pro-Life Obstetricians and Gynecologists, the largest non-sectarian pro-life physician organization in the world, with over 7,000 members across the United States, and associate members on every continent.

Dr. Harrison’s research interests include selective progesterone receptor modulators, endometrial contraception, maternal mortality, and abortion mortality and morbidity. She has authored peer reviewed papers on maternal mortality, mifepristone mortality and morbidity, the approval of mifepristone and ulipristal (Ella) as well as other topics concerning endometrial contraception. Dr. Harrison is a Continuing Medical Education Speaker in the United States and internationally on topics of Medical Abortion with Mifepristone and Misoprostol, Adverse Events associated with Mifepristone and Misoprostol, Emergency Contraception with Ulipristal, Maternal Mortality, and Abortion Morbidity.

She is an Adjunct Professor at Trinity International University in Deerfield, IL, teaching post graduate seminars at the annual Center for Bio Ethics and Human Dignity summer workshops. She is Associate Editor of the peer reviewed medical journal “Issues in Law and Medicine.”

Dr. Harrison is married to Dr. Mark Harrison, M.D., and is the mother of 5 children and 5 grandchildren.

 

Research Authored

featured-image
Abortion

Abortion Pill Reversal: A Second Chance at Choice

featured-image
Maternal & Public Health

National Academies Report Downplays the Health Risks of Abortion

Earlier this month, the National Academies of Sciences, Engineering, and Medicine (NAS) released a report on the safety of abortion in the United States. It examines various methods used for abortion and concludes that abortion is safe and poses minimal health risks. The report also puts a negative spin on pro-life laws, arguing that many of them have no basis in medical research, and states that some abortion-specific regulations create barriers to safe health care.

featured-image
Abortion

Rewire’s Reckless Push for Mail-Order Mifeprex

In pursuit of the possibility that abortion drugs could be distributed via pharmacies or mail order shipment for at-home use, researchers from a group called Gynuity Health Projects sought RU-486 online from 20 websites and had them tested for their potency – that is, whether they contained enough of the drugs in the two-step regimen to effectuate an abortion.

Abortion

Abortion Increases Risk of Preterm Birth: More Evidence in New Publication

The recent systematic review published by Gabrielle Saccone and colleagues joins the long list of over 150 studies over the past four decades which extensively document that having an induced abortion increases a woman’s risk of preterm birth in subsequent pregnancies.

featured-image
Maternal & Public Health

Good News for Pregnant Moms Diagnosed with Cancer, and Good News for their Unborn Babies

Separation of a mother and her unborn child is tragically sometimes necessary to save the life of the mother.  But the number of conditions which truly threaten the mother’s life, and which require a life-saving separation of the mother and her baby are vanishingly small.  A new study by Amant and colleagues, entitled “Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy,” brings tremendous hope to pregnant women who have courageously carried their unborn children to birth, despite the need for chemotherapy or radiation therapy.